Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
5e5 of Anti-CD5 CAR-293 cells were stained with 100 μL of 3 μg/mL of FITC-Labeled Human CD5, Fc Tag (Cat. No. CD5-HF255) and negative control protein respectively. FITC signal was used to evaluate the binding activity (QC tested).
5e5 of anti-CD5 CAR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human CD5, His Tag (Cat. No. CD5-HP2H6) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).
Immobilized Biotinylated Rhesus macaque CD5 Protein, His,Avitag (Cat. No. CD5-R82E3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Monoclonal Anti-Human CD5 Antibody, Mouse IgG1 (2C8A7) with a linear range of 0.2-8 ng/mL (QC tested).
The purity of Rhesus macaque CD5 Protein, His Tag (Cat. No. CD5-R52H3) is more than 90% and the molecular weight of this protein is around 85-105 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CD5 CAR T (CT125B) therapy ( Beijing Boren Hospital) | CD5 CAR T (CT125B); CT125B; CD5 CAR T | Phase 1 Clinical | Beijing Gao Boren Hospital Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
CT-125A | CT-125A; RD-125 | Phase 1 Clinical | Nanjing Iaso Biotherapeutics Co Ltd | Lymphoma, T-Cell, Peripheral; Hematologic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Plasmablastic Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
CD5 CAR T cell therapy (iCell Gene Therapeutics) | Phase 1 Clinical | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell | Details | ||
MT-101 | MT-101 | Phase 2 Clinical | Myeloid Therapeutics Inc | Lymphoma, T-Cell, Peripheral; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides | Details |
CD5 CAR-T Therapy(Xuanwu Hospital) | Phase 1 Clinical | Xuanwu Hospital Of Capital Medical University | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
This web search service is supported by Google Inc.